Dr. Christine Decanter

Dr. Christine Decanter

Dr. Christine Decanter

Dr Christine Decanter,

Numéro RPPS: 1000 2258 571

Doctor in Reproductive Medicine

Graduate in Endocrinology, Gynecology and Reproductive Medicine, 1997 April 30

Head of the Academic IVF and Fertility Preservation Center of the Lille University Hospital

Research team: EA 4308 “gamétogénèse et qualité du gamète”

Member of the French national biomedicine agency

Member of French academic societies FFER, SMR, GRECO

Member of international societies ASRM, ESHRE, ISFP

Hôpital Jeanne de Flandre, rue Eugène Avinée, 59037 Lille Cedex



  • Persistent Chemotherapy-induced amenorrhea: an excess of primordial follicle quiescence? Decanter c and Pigny P, 2018, submitted
  • Dynamics of early recovery of menstrual activity and AMH levels may serve as a model for identifying individual ovarian susceptibility to chemotherapy for breast cancer. Christine Decanter; marc cloquet; audrey dassonneville; emmanuelle d’orazio; audrey mailliez; Pascal Pigny, RBMonline, 2018
  • Prospective assessment of the follicular growth and the oocyte cohort after controlled ovarian hyperstimulation (COH) for fertility preservation in 90 young cancer patients versus 180 matched controls. Decanter C, MD; a,b; Robin G; MD; a,b Mailliez A; MD; c Sigala J; PharmD; a,b Morschhauser F; MD; d Ramdane N, BST; e Devos P, MD; e  Dewailly D, MD; f  Leroy-Martin B, MD;g  Keller L, MD. 2017, RBMonline 2018
  • Polycystic ovary syndrome: what are the obstetrical risks? Bruyneel A, Catteau-Jonard S, Decanter C, Clouqueur E, Tomaszewski C, Subtil D, Dewailly D, Robin G. Gynecol Obstet Fertil. 2014 Feb;42(2):104-11.
  • Use of conventional assisted reproductive technologies and history of cancer: what are the results? Robin G, Decanter C. Gynecol Obstet Fertil. 2014 Jan;42(1):27-31.
  • Fertility preservation strategy in case of haematological malignancies and breast cancer Decanter C; Robin G, Gynecol Obstet Fertil. 2013
  • [Endometriosis and infertility]. Collinet P, Decanter C, Lefebvre C, Leroy JL, Vinatier D.Gynecol Obstet Fertil. 2006 May;34(5):379-84. Epub 2006 May 2. Review. French.



  • Observatory of ovarian reserve parameters (AMH and AFC) and fertility preservation in early young breast cancer patients: NCT (NCT01614704 clinical trial.gov. Dr Audrey Mailliez and Dr Christine Decanter 
  • Observatory of ovarian reserve parameters  in young adult cancer patients and children (hematological malignancies and solid tumors)
  • National Research Project INCA CHACRY about systematic proposal of fertility preservation and AMH/AFC follow-up in a cohort of young breast cancer patients in adjuvant situations including 27 french onco-fertility centers. Dr Audrey Mailliez and Dr Christine Decanter
  • National Research Project about ovarian tissue grafting called PERIDATOR and DATOR
  • National coordination of a European research project regarding AMH follow-up in cancer children. Co-coordination with Dr Isabelle Demesteere (Bruxelles, ERASME center). Called CHANCE protocol. 
  • European project on Fertility preservation breast cancer patient with dr demesteere from the laboratory of reproductive medicine research, ERASMEn, Brussels. FAMHOPE. Beginning in 2018 
  • Analytic studies about hypersensitive assay of AMH. Pr P. Pigny, Lille
  • Fertility preservation after cancer. 3 onco-fertility centers. Work in progress
  • Fertility preservation in young breast cancer patients in neo-adjuvant situation by hemi-ovarian cortectomy. Work in progress